Suppr超能文献

I型干扰素对人类免疫缺陷病毒复制的部分抑制作用:细胞间病毒转移的影响

Partial inhibition of human immunodeficiency virus replication by type I interferons: impact of cell-to-cell viral transfer.

作者信息

Vendrame Daniela, Sourisseau Marion, Perrin Virginie, Schwartz Olivier, Mammano Fabrizio

机构信息

Institut Pasteur, Virus and Immunity Unit, CNRS URA 3015, 25-28 rue du Dr. Roux, 75724 Paris, France.

出版信息

J Virol. 2009 Oct;83(20):10527-37. doi: 10.1128/JVI.01235-09. Epub 2009 Aug 12.

Abstract

Type I interferons (IFN) inhibit several steps of the human immunodeficiency virus type 1 (HIV) replication cycle. Some HIV proteins, like Vif and Vpu, directly counteract IFN-induced restriction factors. Other mechanisms are expected to modulate the extent of IFN inhibition. Here, we studied the impact of IFN on various aspects of HIV replication in primary T lymphocytes. We confirm the potent effect of IFN on Gag p24 production in supernatants. Interestingly, IFN had a more limited effect on HIV spread, measured as the appearance of Gag-expressing cells. Primary isolates displayed similar differences in the inhibition of p24 release and virus spread. Virus emergence was the consequence of suboptimal inhibition of HIV replication and was not due to the selection of resistant variants. Cell-to-cell HIV transfer, a potent means of virus replication, was less sensitive to IFN than infection by cell-free virions. These results suggest that IFN are less active in cell cultures than initially thought. They help explain the incomplete protection by naturally secreted IFN during HIV infection and the unsatisfactory outcome of IFN treatment in HIV-infected patients.

摘要

I型干扰素(IFN)可抑制人类免疫缺陷病毒1型(HIV)复制周期的多个步骤。一些HIV蛋白,如Vif和Vpu,可直接对抗IFN诱导的限制因子。预计还有其他机制可调节IFN抑制的程度。在此,我们研究了IFN对原代T淋巴细胞中HIV复制各个方面的影响。我们证实了IFN对上清液中Gag p24产生的强大作用。有趣的是,以表达Gag的细胞出现情况衡量,IFN对HIV传播的作用较为有限。原代分离株在抑制p24释放和病毒传播方面表现出类似差异。病毒出现是HIV复制未得到最佳抑制的结果,而非由于耐药变异体的选择。细胞间HIV转移是一种有效的病毒复制方式,与无细胞病毒体感染相比,其对IFN的敏感性较低。这些结果表明,IFN在细胞培养中的活性低于最初的设想。它们有助于解释HIV感染期间天然分泌的IFN提供的保护不完整以及HIV感染患者IFN治疗效果不佳的原因。

相似文献

2
Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.
Antimicrob Agents Chemother. 1991 Jan;35(1):62-7. doi: 10.1128/AAC.35.1.62.
5
Restriction of HIV replication in infected T cells and monocytes by interferon-alpha.
AIDS Res Hum Retroviruses. 1990 Aug;6(8):1045-9. doi: 10.1089/aid.1990.6.1045.
8
Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.
J Virol. 2016 Jul 27;90(16):7469-7480. doi: 10.1128/JVI.00458-16. Print 2016 Aug 15.

引用本文的文献

1
Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques.
PLoS Pathog. 2023 Jul 3;19(7):e1011059. doi: 10.1371/journal.ppat.1011059. eCollection 2023 Jul.
2
Mucin Protein of Aedes aegypti Interacts with Dengue Virus 2 and Influences Viral Infection.
Microbiol Spectr. 2023 Feb 27;11(2):e0250322. doi: 10.1128/spectrum.02503-22.
4
The Role of IFITM Proteins in Tick-Borne Encephalitis Virus Infection.
J Virol. 2022 Jan 12;96(1):e0113021. doi: 10.1128/JVI.01130-21. Epub 2021 Oct 6.
5
Human IFITM3 restricts chikungunya virus and Mayaro virus infection and is susceptible to virus-mediated counteraction.
Life Sci Alliance. 2021 Jun 2;4(7). doi: 10.26508/lsa.202000909. Print 2021 Jul.
6
Differential Inhibition of HIV Replication by the 12 Interferon Alpha Subtypes.
J Virol. 2021 Jul 12;95(15):e0231120. doi: 10.1128/JVI.02311-20.
7
Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
PLoS Pathog. 2020 Feb 28;16(2):e1008151. doi: 10.1371/journal.ppat.1008151. eCollection 2020 Feb.
8
IFITM proteins inhibit HIV-1 protein synthesis.
Sci Rep. 2018 Sep 28;8(1):14551. doi: 10.1038/s41598-018-32785-5.
9
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome.
Cytokine Growth Factor Rev. 2018 Apr;40:19-31. doi: 10.1016/j.cytogfr.2018.03.003. Epub 2018 Mar 16.
10
The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus.
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):6104-6109. doi: 10.1073/pnas.1704809114. Epub 2017 May 22.

本文引用的文献

1
IFN inducibility of major histocompatibility antigens in tumors.
Adv Cancer Res. 2008;101:249-76. doi: 10.1016/S0065-230X(08)00407-7.
2
Avoiding the void: cell-to-cell spread of human viruses.
Nat Rev Microbiol. 2008 Nov;6(11):815-26. doi: 10.1038/nrmicro1972.
4
HIV-1 accessory proteins--ensuring viral survival in a hostile environment.
Cell Host Microbe. 2008 Jun 12;3(6):388-98. doi: 10.1016/j.chom.2008.04.008.
5
Management of chronic hepatitis C virus infection in HIV-infected patients.
Clin Infect Dis. 2008 Jul 1;47(1):94-101. doi: 10.1086/588669.
7
The interferon response inhibits HIV particle production by induction of TRIM22.
PLoS Pathog. 2008 Feb 29;4(2):e1000007. doi: 10.1371/journal.ppat.1000007.
9
The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.
Cell Host Microbe. 2008 Apr 17;3(4):245-52. doi: 10.1016/j.chom.2008.03.001. Epub 2008 Mar 13.
10
Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu.
Nature. 2008 Jan 24;451(7177):425-30. doi: 10.1038/nature06553. Epub 2008 Jan 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验